已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Stable incidence and survival of arteriovenous fistulas over 39 years: A long-term national cohort study

医学 期限(时间) 入射(几何) 外科 队列 内科学 人口学 动静脉瘘 数学 几何学 量子力学 物理 社会学
作者
Kristine Lindhard,Ditte Hansen,Brian Pedersen,Marianne Rix,Henrik Post Hansen,Boye L. Jensen,James Heaf
出处
期刊:Journal of Vascular Access [SAGE Publishing]
卷期号:24 (4): 620-629 被引量:2
标识
DOI:10.1177/11297298211046102
摘要

INTRODUCTION: The age and number of comorbidities in the hemodialysis population has increased over time. This may influence the construction and survival of the arteriovenous fistula (AVF). The present study explored the incidence and survival of AVFs over a period of 39 years. METHODS: A retrospective cohort study was conducted based on Danish registries. Incident hemodialysis patients between 1977 and 2015 were included. The incidence of AVF and factors associated with the construction of an AVF were described. Risk factors for AVF survival and repair were explored by Kaplan Meier and Cox proportional hazard analysis. RESULTS: The total number of arteriovenous accesses (AVF and arteriovenous grafts) were 10,187 and there were 4201 central venous catheters (CVC). No significant difference in the proportion of AVFs during the 39 years was seen. Age and renal diagnosis did not influence the proportion of AVFs. Patients with CVCs were found to have a significantly higher prevalence of comorbidities ( p < 0.01). AVF survival remained stable during the 39 years. The first constructed AVF had the best survival, 35% still functioning after 15 years. Factors such as brachiocephalic AVF, female sex, and diabetic nephropathy increased the risk of AVF failure (Odds Ratio (OR): 2.46, 95% Confidence Interval (CI) (2.29-2.65), 1.17 (1.10-1.25), and 1.21 (1.12-1.3)), respectively. CONCLUSION: Despite an older dialysis population, the proportion and survival of the AVF in the Danish dialysis population has not changed, probably because of increased awareness of AVF as the first choice of vascular access and improved surveillance, surgery, and repair.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
共享精神应助如意的尔烟采纳,获得10
刚刚
坐雨赏花完成签到 ,获得积分10
刚刚
雪城完成签到,获得积分10
1秒前
呵呵哒发布了新的文献求助10
1秒前
2秒前
kiven发布了新的文献求助10
2秒前
浮生完成签到 ,获得积分10
2秒前
科研通AI6.1应助archer01采纳,获得10
6秒前
依山观澜完成签到,获得积分10
6秒前
ShellyHan发布了新的文献求助10
6秒前
了U完成签到 ,获得积分10
6秒前
微笑的冬天完成签到,获得积分10
10秒前
tzy完成签到,获得积分10
12秒前
十一完成签到 ,获得积分10
13秒前
oleskarabach发布了新的文献求助10
14秒前
15秒前
火星上的摩托完成签到 ,获得积分10
15秒前
丘比特应助bo采纳,获得10
17秒前
wzy完成签到 ,获得积分10
17秒前
搜集达人应助Ditf采纳,获得10
20秒前
儿学化学打断腿完成签到,获得积分10
20秒前
风和日丽完成签到,获得积分10
20秒前
严明完成签到,获得积分0
21秒前
21秒前
yylfy完成签到,获得积分20
22秒前
yyds完成签到,获得积分10
23秒前
南瓜小笨111111完成签到 ,获得积分10
23秒前
Aloha完成签到,获得积分0
24秒前
迷你的寄风完成签到 ,获得积分10
24秒前
今后应助kiven采纳,获得10
24秒前
生动的无招完成签到 ,获得积分10
24秒前
小新小新完成签到 ,获得积分10
24秒前
慈祥的惜梦完成签到,获得积分10
26秒前
大鱼完成签到,获得积分10
28秒前
28秒前
30秒前
GingerF应助科研通管家采纳,获得50
30秒前
斯文败类应助科研通管家采纳,获得10
30秒前
顾矜应助科研通管家采纳,获得10
30秒前
情怀应助科研通管家采纳,获得10
30秒前
高分求助中
Signals, Systems, and Signal Processing 610
Annie Ernaux: De la perte au corps glorieux 600
Petrology and Plate Tectonics,2025 500
Direct and Iterative Linear System Solvers 400
Cardiopulmonary Bypass and Mechanical Support: Principles and Practice, Fifth Edition 400
Circular Polar Constellations Providing Continuous Single or Multiple Coverage Above a Specified Latitude 400
Burger's Medicinal Chemistry and Drug Discovery 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6751654
求助须知:如何正确求助?哪些是违规求助? 8480595
关于积分的说明 18084816
捐赠科研通 6028527
什么是DOI,文献DOI怎么找? 3006966
邀请新用户注册赠送积分活动 1983863
关于科研通互助平台的介绍 1952744